Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial - Henderson,S.T.; Vogel,J.L.; Barr,L.J.; Garvin,F.; Jones,J.J.; Costantini,L.C. (Nutr Metab (Lond), 2009)